| TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma NL Albert, M Unterrainer, DF Fleischmann, S Lindner, F Vettermann, ... European journal of nuclear medicine and molecular imaging 44, 2230-2238, 2017 | 103 | 2017 |
| TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis M Unterrainer, C Mahler, L Vomacka, S Lindner, J Havla, M Brendel, ... European journal of nuclear medicine and molecular imaging 45, 1423-1431, 2018 | 67 | 2018 |
| TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis L Vomacka, NL Albert, S Lindner, M Unterrainer, C Mahler, M Brendel, ... EJNMMI research 7, 1-9, 2017 | 64 | 2017 |
| Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study M Unterrainer, DF Fleischmann, C Diekmann, L Vomacka, S Lindner, ... European journal of nuclear medicine and molecular imaging 46, 580-590, 2019 | 60 | 2019 |
| TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study M Unterrainer, DF Fleischmann, F Vettermann, V Ruf, L Kaiser, D Nelwan, ... European journal of nuclear medicine and molecular imaging 47, 1368-1380, 2020 | 55 | 2020 |
| Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics Z Li, L Kaiser, A Holzgreve, VC Ruf, B Suchorska, V Wenter, S Quach, ... European journal of nuclear medicine and molecular imaging 48, 4415-4425, 2021 | 36 | 2021 |
| Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET M Song, L Beyer, L Kaiser, H Barthel, T van Eimeren, K Marek, ... Journal of cerebral blood flow & metabolism 41 (11), 2957-2972, 2021 | 34 | 2021 |
| Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid … A Gosewisch, A Delker, S Tattenberg, H Ilhan, A Todica, J Brosch, ... EJNMMI research 8, 1-16, 2018 | 31 | 2018 |
| Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F] GE180 PET quantification M Deussing, T Blume, L Vomacka, C Mahler, C Focke, A Todica, ... Neuroimage 165, 83-91, 2018 | 30 | 2018 |
| Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy M Song, M Scheifele, H Barthel, T van Eimeren, L Beyer, K Marek, ... European journal of nuclear medicine and molecular imaging 48, 3872-3885, 2021 | 29 | 2021 |
| 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT A Gosewisch, H Ilhan, S Tattenberg, A Mairani, K Parodi, J Brosch, ... EJNMMI research 9, 1-14, 2019 | 28 | 2019 |
| Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation L Vomacka, M Unterrainer, A Holzgreve, E Mille, A Gosewisch, J Brosch, ... EJNMMI research 8, 1-13, 2018 | 28 | 2018 |
| Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau M Brendel, M Deussing, T Blume, L Kaiser, F Probst, F Overhoff, F Peters, ... Alzheimer's research & therapy 11, 1-11, 2019 | 25 | 2019 |
| Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT A Gosewisch, M Schleske, FJ Gildehaus, I Berg, L Kaiser, J Brosch, ... European journal of nuclear medicine and molecular imaging 48, 1260-1261, 2021 | 24 | 2021 |
| A kinome-wide selective radiolabeled TrkB/C inhibitor for in vitro and in vivo neuroimaging: synthesis, preclinical evaluation, and first-in-human V Bernard-Gauthier, JJ Bailey, AV Mossine, S Lindner, L Vomacka, ... Journal of Medicinal Chemistry 60 (16), 6897-6910, 2017 | 23 | 2017 |
| First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases JJ Bailey, L Kaiser, S Lindner, M Wüst, A Thiel, JP Soucy, P Rosa-Neto, ... ACS chemical neuroscience 10 (6), 2697-2702, 2019 | 22 | 2019 |
| 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates J Brosch, A Gosewisch, L Kaiser, M Seidensticker, J Ricke, J Zellmer, ... Physica Medica 80, 317-326, 2020 | 21 | 2020 |
| Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T J Brosch-Lenz, C Uribe, A Gosewisch, L Kaiser, A Todica, H Ilhan, ... EJNMMI physics 8, 1-17, 2021 | 20 | 2021 |
| In response to: The validity of 18F-GE180 as a TSPO imaging agent NL Albert, M Unterrainer, M Brendel, L Kaiser, M Zweckstetter, ... European journal of nuclear medicine and molecular imaging 46, 1208-1211, 2019 | 20 | 2019 |
| TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy C Mahler, AM Schumacher, M Unterrainer, L Kaiser, T Höllbacher, ... Brain 144 (9), 2683-2695, 2021 | 18 | 2021 |
